Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT
| Image |  |
|---|---|
| Description | scholarly article by Sarah Brown et al published June 2018 in Health Technology Assessment |
| Author/s |
author: Christopher McCabe Bryony Dawkins Colin C Everett Paul Emery Linda D. Sharples Claire Hulme Maya Hema Buch |
| Publication date | June 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |